Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Allarity Therapeutics, Inc.
organization6 mentionslast seen Nov 2, 2026
A clinical-stage biopharmaceutical company focused on developing personalized cancer treatments, trading on NASDAQ under the symbol ALLR.
Relationships 13
- Allarity Therapeutics, Inc.developsstenoparib99% confidence6 sources
- Allarity Therapeutics, Inc.developsDrug Response Predictor99% confidence4 sources
- Allarity Therapeutics, Inc.acquiresstenoparib99% confidence4 sources
- Allarity Therapeutics, Inc.employsThomas Jensen99% confidence3 sources
- Allarity Therapeutics, Inc.employsThomas H. Jensen99% confidence2 sources
- Allarity Therapeutics, Inc.ownsALLR Sponsor LLC99% confidence1 source
- Allarity Therapeutics, Inc.employsThomas H. Jensen97% confidence1 source
- Allarity Therapeutics, Inc.commercializesstenoparib97% confidence1 source
- Allarity Therapeutics, Inc.conforms toCLIA certification95% confidence1 source
- Allarity Therapeutics, Inc.developsDrug Response Predictor95% confidence1 source
- Allarity Therapeutics, Inc.authoredJapanese Patent No. 791728395% confidence1 source
- Allarity Therapeutics, Inc.developsproteomics88% confidence1 source
- Allarity Therapeutics, Inc.developscell line research88% confidence1 source
Relationship
Allarity Therapeutics, Inc.employsThomas H. Jensen
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 2, 2026Allarity Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Thomas H. Jensen Chief Executive Officer of Allarity Therapeutics, Inc.
- filingSEC EDGARSep 14, 2026Allarity Therapeutics, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Thomas H. Jensen Chief Executive Officer